Self-amplifying COVID-19 mRNA vaccination induces longitudinally enhanced antibody function in a Phase 3 trial.

Levine KS, Blanc R, Wang Q, Malca H, Sekulovich R, Jin H, Liu S, Verhoeven C, Sullivan B, Smolenov I, McNamara RP

Open source

DOI
10.1038/s41541-026-01431-x
Published
2026 Mar 30
Container
NPJ vaccines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41541-026-01431-x,
  title = {Self-amplifying COVID-19 mRNA vaccination induces longitudinally enhanced antibody function in a Phase 3 trial.},
  author = {Levine KS and Blanc R and Wang Q and Malca H and Sekulovich R and Jin H and Liu S and Verhoeven C and Sullivan B and Smolenov I and McNamara RP},
  year = {2026},
  journal = {NPJ vaccines},
  doi = {10.1038/s41541-026-01431-x},
  url = {https://doi.org/10.1038/s41541-026-01431-x}
}

RIS

TY  - JOUR
TI  - Self-amplifying COVID-19 mRNA vaccination induces longitudinally enhanced antibody function in a Phase 3 trial.
AU  - Levine KS
AU  - Blanc R
AU  - Wang Q
AU  - Malca H
AU  - Sekulovich R
AU  - Jin H
AU  - Liu S
AU  - Verhoeven C
AU  - Sullivan B
AU  - Smolenov I
AU  - McNamara RP
PY  - 2026
JO  - NPJ vaccines
DO  - 10.1038/s41541-026-01431-x
UR  - https://doi.org/10.1038/s41541-026-01431-x
ER  - 

APA

KS, L., R, B., Q, W., H, M., R, S., H, J., S, L., C, V., B, S., I, S., & RP, M. (2026). Self-amplifying COVID-19 mRNA vaccination induces longitudinally enhanced antibody function in a Phase 3 trial.. NPJ vaccines. https://doi.org/10.1038/s41541-026-01431-x

Source records